1[1]Riechmann L,Clark M,Waldmann H,et al.Reshaping human antibodies for therapy.Nature,1988,332:323
2[2]Carter P,Gorman C D,Presta L,et al.Humanization of an anti-p185 HER-2 antibody for human cancer therapy.Proc Nat1 Acad Sci,1992,89:4285
3[3]Baselga J,Norton L,Albanell J,et al.Recombinant humanized anti-HER-2 antibody(Herceptin)enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.Cancer Res,1998,58:2825
4[4]Baselga J,Tripathy D,Mendelsohn J,et al.Phase Ⅱ study of weekly intravenous recombinant humanized anti-p185 HER-2 monoclonal antibody in patients with HER2/neu overexpressing metastatic breast cancer.J Clin Oncol,1996,14:737
5[5]Pegran M D,Lipton A,Hayes D F,et al.Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185 HER-2 monoclonal antibody plus cisplatin in patients with HER2/neu overexpressing metastatic breast cancer refractory to chemotherapy.J Clin Onco1,1998,16:2659
6[6]Colomer R,Shamon L A,Tsai M S,et al.Herceptin:from the bench to the clinic.Cancer invest,2001,19:49
7[7]Maloney D G,Grillo-Lopez A J,Bodkin D J,et al.IDEC-C2B8:results of a phase Ⅰ multiple dose trial in patients with relapsed non-Hodgkins lymphoma.J Clin Oncol,1997,15:3266
8[8]Mc Laughlin P,Grillo-Lopez A J,Link B K,et al.Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphom:half of patient respond to a four-dose treatment program.J Clin Oncol, 1998,16:2825
9[9]Herbst R S,Langer C J.Epidermal growth factor receptors as a target for cancer treatment:the emerging role of IMC-C225 in the treatment of lung and head and neck cancers.Semin Oncol,2002,29(1suppl 4):27
10[10]Gunnett K,Motzer R,Anato R,et al.Phase Ⅱ study of anti-epidermal growth factor receptor antibody C225 alone in patients with metastatic renal cell carcinoma.Proc ASCO, 1999,1309
4Plwa JL,Britta E,Jayne L,et al.Targeting rat anti-mouse transferrin receptor monoclonal antibody through blood-brain barrier in mouse[J].J pharmacology and experiment therapeuties,2000,292:1048-1057.
5Lode HN,Reisfeld RA,Handgretinger,et al.Targeted therapy with a novel enediyene antibiotic calicheamicin theta(Ⅰ),effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastoma[J].Cancer Res,1998,58:2925-2928.
